895 Shares in McKesson Co. (NYSE:MCK) Acquired by First Western Trust Bank

First Western Trust Bank purchased a new stake in shares of McKesson Co. (NYSE:MCK) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 895 shares of the company’s stock, valued at approximately $414,000.

Other institutional investors have also recently made changes to their positions in the company. OFI Invest Asset Management bought a new stake in McKesson during the third quarter worth about $26,000. BKM Wealth Management LLC purchased a new position in shares of McKesson during the 4th quarter valued at about $31,000. WASHINGTON TRUST Co boosted its stake in McKesson by 42.5% in the fourth quarter. WASHINGTON TRUST Co now owns 114 shares of the company’s stock worth $53,000 after buying an additional 34 shares in the last quarter. Milestone Investment Advisors LLC bought a new position in McKesson during the third quarter valued at approximately $61,000. Finally, Orion Capital Management LLC purchased a new position in shares of McKesson during the third quarter worth approximately $63,000. Institutional investors own 85.07% of the company’s stock.

Insider Transactions at McKesson

In other McKesson news, EVP Leann B. Smith sold 186 shares of the business’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total transaction of $92,256.00. Following the transaction, the executive vice president now owns 1,511 shares in the company, valued at $749,456. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, EVP Leann B. Smith sold 186 shares of the company’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total transaction of $92,256.00. Following the transaction, the executive vice president now directly owns 1,511 shares in the company, valued at approximately $749,456. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Brian S. Tyler sold 3,473 shares of the firm’s stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the completion of the sale, the chief executive officer now directly owns 43,445 shares of the company’s stock, valued at approximately $22,789,074.75. The disclosure for this sale can be found here. Company insiders own 0.21% of the company’s stock.

Wall Street Analyst Weigh In

MCK has been the topic of several recent research reports. Wells Fargo & Company increased their target price on shares of McKesson from $502.00 to $551.00 and gave the company an “equal weight” rating in a report on Thursday. Morgan Stanley lifted their price objective on McKesson from $522.00 to $548.00 and gave the stock an “overweight” rating in a report on Monday, April 15th. StockNews.com upgraded McKesson from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 4th. Robert W. Baird lifted their price target on McKesson from $603.00 to $671.00 and gave the stock an “outperform” rating in a research note on Wednesday. Finally, Citigroup increased their price objective on McKesson from $575.00 to $620.00 and gave the company a “buy” rating in a research note on Tuesday, April 30th. Two research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $571.47.

McKesson Stock Performance

MCK traded up $11.51 during trading on Thursday, reaching $555.12. 969,156 shares of the company traded hands, compared to its average volume of 716,168. The company has a market cap of $72.95 billion, a P/E ratio of 24.80, a PEG ratio of 1.41 and a beta of 0.45. The firm has a fifty day simple moving average of $531.56 and a 200 day simple moving average of $494.15. McKesson Co. has a 12-month low of $373.28 and a 12-month high of $566.01.

McKesson (NYSE:MCK) last released its quarterly earnings results on Tuesday, May 7th. The company reported $6.18 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $6.34 by ($0.16). McKesson had a net margin of 0.99% and a negative return on equity of 262.63%. The business had revenue of $76.36 billion for the quarter, compared to analysts’ expectations of $79.32 billion. During the same period in the previous year, the company earned $7.19 EPS. McKesson’s revenue for the quarter was up 10.8% compared to the same quarter last year. As a group, sell-side analysts expect that McKesson Co. will post 27.59 earnings per share for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Monday, June 3rd will be paid a $0.62 dividend. This represents a $2.48 annualized dividend and a dividend yield of 0.45%. The ex-dividend date is Friday, May 31st. McKesson’s payout ratio is 11.08%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.